Castle Biosciences (CSTL)'s 30-day implied volatility (IV30) was 46.6% at the close on November 6, 2026, down from 61.4% the day before, against a 52-week range of 26.7% to 79.7%. Its 20-day historical volatility was 56.1%.
Data as of November 6, 2026.